TOT BIOPHARM International Co. Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
37.00
-38.00
-50.00
-314.00
-324.00
-339.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
7.00
12.00
47.00
47.00
-22.00
-36.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
110.00
48.00
62.00
-213.00
-295.00
-284.00
Cash Flow from Investing Activities
-132.00
-185.00
-324.00
-130.00
14.00
-57.00
Cash Flow from Financing Activities
52.00
59.00
563.00
258.00
-69.00
661.00
Net Cash Inflow / Outflow
32.00
-73.00
308.00
-87.00
-352.00
320.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
1.00
3.00
7.00
-1.00
-1.00
2.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of TOT BIOPHARM International Co. Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
37.6843680939251
694.602583584038
-657.00
-94.57%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
7.96579257087976
-183.886532137174
190.00
104.33%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
110.797918689366
279.524833061032
-169.00
-60.36%
Cash Flow from Investing Activities
-132.822841826
178.247483932286
-310.00
-174.52%
Cash Flow from Financing Activities
52.471012858
-201.969217382536
253.00
125.98%
Net Cash Inflow / Outflow
32.1537422733102
269.808018984468
-237.00
-88.08%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
1.70765255194441
14.0049193736859
-13.00
-87.81%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 128.83% vs -22.23% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
110.80
48.42
128.83%






